OA
Operose Advisors Portfolio holdings
AUM
$517M
Turnover
40.26%
1-Year Est. Return
24.68%
This Fund
S&P 500
This Quarter
Est. Return
+3.68%
1 Year Est. Return
+24.68%
3 Year Est. Return
+68.8%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$221M
AUM Growth
+$19.3M
(+9.6%)
Cap. Flow
+$12.4M
Cap. Flow
% of AUM
5.62%
Top 10 Holdings %
Top 10 Hldgs %
70.98%
Holding
362
New
18
Increased
66
Reduced
26
Closed
4
Avg Time Held
1.2
years
Top 10 Avg Time Held
1.3
years
Top 20 Avg Time Held
1.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$2.92M |
| 2 |
Vanguard High Dividend Yield ETF
VYM
|
+$1.27M |
| 3 |
iShares International Select Dividend ETF
IDV
|
+$1.05M |
| 4 |
Oracle
ORCL
|
+$929K |
| 5 |
Schwab International Equity ETF
SCHF
|
+$822K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Global Min Vol Factor ETF
ACWV
|
+$468K |
| 2 |
Old National Bancorp
ONB
|
+$294K |
| 3 |
iShares National Muni Bond ETF
MUB
|
+$212K |
| 4 |
iShares US Real Estate ETF
IYR
|
+$177K |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$149K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 84.12% |
| 2 | Financials | 5.12% |
| 3 | Technology | 4.2% |
| 4 | Consumer Discretionary | 2.01% |
| 5 | Healthcare | 1.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
126
Analog Devices
ADI
$197B
| $97.4K | 0.04% |
500
| – | – |
2021 Q4
6 quarters
|
|
127
Paychex
PAYX
$38.4B
| $97.3K | 0.04% |
870
| – | – |
2021 Q4
6 quarters
|
|
128
ExxonMobil
XOM
$728B
| $96.6K | 0.04% |
901
| – | – |
2021 Q4
6 quarters
|
|
129
Royce Value Trust
RVT
$2.04B
| $96.6K | 0.04% |
7,000
| – | – |
2022 Q2
4 quarters
|
|
130
TJX Companies
TJX
$157B
| $95.3K | 0.04% |
1,124
| – | – |
2021 Q4
6 quarters
|
|
131
Vanguard FTSE Emerging Markets ETF
VWO
$124B
| $88.8K | 0.04% |
2,184
+259
| +13% | +$10.4K |
2021 Q4
6 quarters
|
|
132
Boeing
BA
$146B
| $87.4K | 0.04% |
414
| – | – |
2021 Q4
6 quarters
|
|
133
Nuveen Quality Municipal Income Fund
NAD
$2.37B
| $84.8K | 0.04% |
7,527
| – | – |
2021 Q4
6 quarters
|
|
134
Coca-Cola
KO
$395B
| $84.3K | 0.04% |
1,400
| – | – |
2021 Q4
6 quarters
|
|
135
DELISTED
PHYSICIANS REALTY TRUST
DOC
| $83.9K | 0.04% |
6,000
| – | – |
2022 Q2
4 quarters
|
|
136
Gilead Sciences
GILD
$190B
| $83.8K | 0.04% |
1,087
| – | – |
2022 Q1
5 quarters
|
|
137
3M
MMM
$84.8B
| $80.2K | 0.04% |
958
| – | – |
2021 Q4
6 quarters
|
|
138
Southern Company
SO
$103B
| $80K | 0.04% |
1,139
| – | – |
2021 Q4
6 quarters
|
|
139
Vanguard Morningstar Mid-Cap ETF
VO
$105B
| $76.9K | 0.03% |
1,396
+1,108
| +385% | +$58.1K |
2022 Q2
4 quarters
|
|
140
Schwab US Mid-Cap ETF
SCHM
$14.4B
| $75.4K | 0.03% |
3,183
+12
| +0.4% | +$270 |
2022 Q3
3 quarters
|
|
141
Netflix
NFLX
$293B
| $75.3K | 0.03% |
1,710
| – | – |
2021 Q4
6 quarters
|
|
142
State Street SPDR S&P Dividend ETF
SDY
$21.1B
| $73.5K | 0.03% |
600
| – | – |
2021 Q4
6 quarters
|
|
143
Old Republic International
ORI
$9.28B
| $73K | 0.03% |
2,900
| – | – |
2023 Q1
1 quarter
|
|
144
First Trust Value Line Dividend Fund
FVD
$7.74B
| $70.4K | 0.03% |
1,755
| – | – |
2021 Q4
6 quarters
|
|
145
Opko Health
OPK
$1.02B
| $69.4K | 0.03% |
32,000
| – | – |
2022 Q3
3 quarters
|
|
146
Bristol-Myers Squibb
BMY
$121B
| $69.3K | 0.03% |
1,084
-187
| -15% | -$12.5K |
2021 Q4
6 quarters
|
|
147
Johnson Controls International
JCI
$92.1B
| $68.1K | 0.03% |
1,000
| – | – |
2023 Q1
1 quarter
|
|
148
Bath & Body Works
BBWI
$3.79B
| $67.5K | 0.03% |
1,800
| – | – |
2021 Q4
6 quarters
|
|
149
Schwab US Dividend Equity ETF
SCHD
$112B
| $64.6K | 0.03% |
2,667
| – | – |
2021 Q4
6 quarters
|
|
150
Honeywell
HON
$66.1B
| $61.8K | 0.03% |
316
| – | – |
2021 Q4
6 quarters
|
|
Similar funds
KPDZUSZIDPFAS
MADR
AWM
CPW
PDIP
BP
DAC
PIN
Operose Advisors's Q2 2023 Portfolio in Review
As of Q2 2023, Operose Advisors held 362 positions worth $221M, up 9.6% from $201M the previous quarter. Its ten largest holdings account for 71% of the portfolio.
Operose Advisors deployed $12.4M of net new capital in Q2 2023, opening 18 new positions and adding to 66 existing holdings. Its largest new stake was TE Connectivity: 5,500 shares worth $771K.
By sector, the portfolio is most concentrated in Miscellaneous at 84% of assets, down from 87% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was iShares MSCI Global Min Vol Factor ETF, an estimated $468K trimmed.
- Operose Advisors's largest Q2 2023 buy was TE Connectivity: 5,500 shares worth $771K.
- Operose Advisors added most to Vanguard Morningstar Total Stock Market ETF in Q2 2023, an estimated $2.92M increase.
- Operose Advisors's biggest Q2 2023 reduction was iShares MSCI Global Min Vol Factor ETF, cutting an estimated $468K.
- Operose Advisors fully exited Clorox in Q2 2023, selling an estimated $19.5K.
- Operose Advisors's ten largest holdings make up 71% of its $221M portfolio in Q2 2023.
- Operose Advisors opened 18 new positions and closed 4 in Q2 2023.
- Operose Advisors's portfolio value rose 9.6% quarter-over-quarter to $221M.
Based on Operose Advisors's 13F filing for Q2 2023, filed 9 Aug 2023.